4'-(4-Pyridyl)-2,2':6',2''-terpyridine, 95.0%, 25g

3-Iodo-1H-pyrrolo[2,3-b]pyridine, 97.0%, 1g

3-CYCLOHEXYLAZETIDINE HYDROCHLORIDE, 95%, 250mg

3-(ethoxycarbonyl)-1-[4-(propan-2-yl)phenyl]-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

1,2,3,5-Tetrahydro-8-thia-5,7-diaza-cyclopenta[a]indene-4-one, 95.0%, 2.5g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2-Iodo-4-methoxybenzonitrile, 97%, 5g

4-(3-Chloro-4-fluorophenyl)thiazol-2-ylamine, 500mg

Diéthylène glycol, min 99 %, pour la synthèse, 5 l, emballage plastique.

(2-Fluoro-5-(propylcarbamoyl)phenyl)boronic acid, 98%, 1g

n-Butylaminopropyltrimethoxysilane, 25g

4,4,5,5-Tetramethyl-2-(phenylethynyl)-1,3,2-dioxaborolane, 95.0%, 10g

DL-4-Methylphenylglycine, 97.0%, 250mg